White Paper

Reducing ADC Timelines With Integrated Development And Manufacturing Services

By Thomas Rohrer, Senior Director of Technical Support, Bioconjugates, Samsung Biologics

Isolated Antibody Drug Conjugates ADCs GettyImages-1438509824

Antibody-Drug Conjugates (ADCs) are a revolutionary class of cancer drugs designed to deliver potent chemotherapy directly to tumors. Unlike traditional treatments, ADCs minimize harm to healthy cells, offering a promising new approach in the fight against cancer. ADCs have proven to be highly effective in cancer treatment, but their manufacturing poses challenges due to the specialized capabilities required. Samsung Biologics, a leading contract development and manufacturing organization (CDMO), is making significant strides in the field of antibody-drug conjugates (ADCs). Samsung Biologics aims to simplify ADC projects by offering integrated capabilities for their development and manufacturing.

This article explores the growing impact of ADCs and the challenges associated with their complex manufacturing process. The intricate nature of ADCs, with their unique combination of antibodies, linkers, and payloads, necessitates a multifaceted production approach. The article highlights the benefits of integrated manufacturing, where all aspects of ADC development and production are streamlined under one roof. This integrated approach can significantly reduce development timelines and ensure consistent quality control.

The future of ADCs is brimming with potential. As scientific understanding continues to evolve, researchers are developing even more effective targeting agents, payloads, and linkers. This continuous innovation will allow ADCs to target a wider range of cancers and improve patient outcomes.

Learn how a CDMO partner with expertise and integrated manufacturing capabilities can help bring these innovative treatments to patients safely and efficiently.

access the White Paper!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Outsourced Pharma? Subscribe today.

Subscribe to Outsourced Pharma X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Outsourced Pharma